Radiopharmaceutical supply chain structure: 2/6 Step 2 – Isotope Enrichment Creating materials for nuclear medicine is incredibly tough, and it all comes down to how "clean" the raw ingredients are. To illustrate that, let’s look at two

Radiopharmaceutical supply chain structure: 1/6 Step 1 - Source material acquisition: is raw material supply a real threat to nuclear medicine? Prior to the enrichment stage, the industry needs to secure various ores (Nickel, Tellurium, Yttrium, Zinc,

Typical chain structure for a radiopharmaceutical Over the next 7 weeks, we’ll take you inside each step of the radiopharmaceutical supply chain. Radiopharmaceuticals play a critical role in modern healthcare, from cancer diagnostics to targeted therapies. But

SNMMI 2026 – Let’s connect in Los Angeles ! We are attending the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Los Angeles !Vincent Brechin, Ph.D. is on site to discuss the latest developments

One week to go before SNMMI 2026 ! One week to go before SNMMI 2026 ! The NucAdvisor-MEDraysintell team will be attending the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting, from May 30-June

April 7th : World Health Day On this World Health Day, it is worth highlighting the growing role of nuclear medicine in modern healthcare, enabling earlier diagnosis, more precise treatment and improved patient outcomes across a wide

2026 PSMA & Beyond Conference March 31 has a special meaning for our field: on this day in 1941, Iodine‑131 was used for the very first time in a patient, the spark that launched modern theranostics.Today, we

2026 PSMA & Beyond Conference Proud to see our CEO, Nicolas Mario, share his expertise at the 2026 PSMA & Beyond Conference UCLA. His insights into raw material and enrichment technology constraints clarify for the medical community

February 4th : World Cancer Day Today, on World Cancer Day, we stand alongside the global community in raising awareness and strengthening our shared commitment to improving cancer care. At MEDraysintell, we are proud to be at

Looking back at the WNE 2025 session dedicated to Nuclear Medicine It was a privilege for MEDraysintell to take part in the “Beyond Electricity: Nuclear medicine, a new leading actor in the fight against cancer” session at

Vincent BRECHIN - Keynote Speaker at NOAR Europe Annual Meeting Our Head of Medical & Science, Vincent Brechin, Ph.D., is gearing up for his Keynote Speech at the NOAR Europe Annual Meeting in Nantes! Catch his presentation on:

Nicolas MARIO : Keynote Speaker at WNE 2025 Join Nicolas Mario, our Head of Nuclear Medicine BU, at WNE 2025 where he will discuss “The radiopharmaceutical supply chain challenge: how can the nuclear industry contribute to support